HHealthcare Read More Pfizer amps up push into obesity treatments with $4.9B deal for MetseraSeptember 23, 2025 Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera. The COVID-19…